Qupha Global, an emerging name in the Indian Health care industry, has announced strategic collaborations with two innovative healthcare startups: Anakaas Life Bio Science and MEDXA Pharma Pvt Ltd. These alliances aim to revolutionize patient care, enhance treatment accessibility, and drive healthcare innovation across India.
Bengaluru (Karnataka) [India], May 22: Qupha Global, an emerging name in the Indian Health care industry, has announced strategic collaborations with two innovative healthcare startups: Anakaas Life Bio Science and MEDXA Pharma Pvt Ltd. These alliances aim to revolutionize patient care, enhance treatment accessibility, and drive healthcare innovation across India.
Anakaas Life Bio Science Pvt Ltd: Emerging healthcare start up on Anti-Cancer Treatments.
Qupha Global Pvt Ltd has partnered with Anakaas Life Bio Science Pvt Ltd, a forward-thinking start up in anti-cancer treatments, particularly in southern states of India. In this collaboration Qupha Global Pvt Ltd taken a 1st manufacturing contract of Paclitaxel injections (30/100/260 mg), a key chemotherapy drug renowned for its effectiveness in slowing down various cancers.
Mr. K Anandan, the founder of Anakaas Life Bio Science Pvt Ltd, expressed his excitement, stating, “Our partnership with Qupha Global will empower us to expand our reach and impact in the fight against cancer. Together, we aim to provide cutting-edge treatments to those in need, making a meaningful difference in their lives. The collaboration is expected to significantly improve access to life-saving treatments in the region. I would also promise to collaborate on getting couple of more formulations from Qupha Global in coming months which are… Docetaxel RTU 20/80/ 120 mg, Albumin Bound Paclitaxel 100mg, Doxorubicin RTU and Tamoxifen Tab.”
MEDXA Pharma Pvt Ltd: Revolutionizing Cardio-Diabetic and General segment Treatments!
In another major development, Qupha Global has joined hands with MEDXA Pharma, a startup focused on cardio-diabetic and general segment treatments in western India. This partnership aims to support MEDXA Pharma’s mission of delivering essential medications at affordable prices, thus expanding access to critical healthcare services.
Mr. Najib Ruknuddin, Co-founder of MEDXA Pharma, highlighted the importance of the collaboration, stating, “Our alliance with Qupha Global is a pivotal moment for us as we work to enhance access to vital medications for those affected by cardio-diabetic and other core segment. This collaboration will undoubtedly accelerate our goal of providing high-quality healthcare solutions to a wider audience.”
Some of the key formulations Qupha Global taken manufacturing contract for Medxa Pharma are…
- Clinidipine + Metoprolol
- Atorvastatin + Fibrates
- Telmisartan + Amlodipine / Metoprolol / Clinidipine + Chlorthalidone
- Levocarnitine + Methylcobalamine
- Calcitriol, Methylcobalamine, Omega-3 combination
- Bilastine and Montelukast combination
Mr Nazib Ruknuddin also promises to give manufacturing contract to Qupha Global for their new launches like 1. Bilastin Syrup 2. Ears Drop (Clotrimazole + Beclomethasone + Lignocaine) 3. Amuno Acid, Multivitamin and Antioxidant syrup.
Broader Implications and Strategic Growth
The broader impact of these collaborations extends beyond the companies themselves. Qupha Global’s senior management emphasized that these partnerships will foster deeper engagement within the Indian healthcare sector. By aligning with innovative startups like Anakaas and MEDXA Pharma, Qupha Global is set to lead in healthcare innovation, foster growth, and significantly contribute to the evolution of healthcare in India.
These alliances underline Qupha Global’s commitment to significant progress through collaboration. The company’s vision of advancing healthcare solutions is clear, and these partnerships are a testament to unlocking new opportunities, benefiting patients and healthcare providers across the nation.
Expanding Horizons: International Medical Tourism
As part of its strategic vision, Qupha Global is also exploring international medical tourism in collaboration with Anakaas and MEDXA Pharma. This ambitious initiative highlights Qupha Global’s commitment to extending its reach beyond domestic boundaries, offering world-class healthcare services in India for Global citizens. The venture aims to enrich the India’s health care excellence at Global level.
Qupha Global senior Management says, “alliance with these two new start-ups is just beginning, starting from June 2024, we are very confident of adding 5 to 6 new health care startups collaboration every month in various healthcare segments. These collaborations will have a significant impact in Qupha Global reach in Indian health care industry.
For More information visit: https://quphaglobal.com/
If you have any objection to this press release content, kindly contact [email protected] to notify us. We will respond and rectify the situation in the next 24 hours.
